Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Zylox-Tonbridge Medical Technology Co Ltd
Cost of Revenue
Zylox-Tonbridge Medical Technology Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
|
Cost of Revenue
-¥142.8m
|
CAGR 3-Years
-133%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
APT Medical Inc
SSE:688617
|
Cost of Revenue
-¥486.1m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Cost of Revenue
-¥3.7B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-14%
|
|
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Cost of Revenue
-¥13.3B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Cost of Revenue
-¥2.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-16%
|
|
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Cost of Revenue
-¥5.9B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Zylox-Tonbridge Medical Technology Co Ltd
Glance View
Zylox-Tonbridge Medical Technology Co., Ltd. operates as a medical devices company. The company is headquartered in Hangzhou, Zhejiang and currently employs 487 full-time employees. The company went IPO on 2021-07-05. The firm's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The firm's products are sold to domestic and foreign markets.
See Also
What is Zylox-Tonbridge Medical Technology Co Ltd's Cost of Revenue?
Cost of Revenue
-142.8m
CNY
Based on the financial report for Dec 31, 2023, Zylox-Tonbridge Medical Technology Co Ltd's Cost of Revenue amounts to -142.8m CNY.
What is Zylox-Tonbridge Medical Technology Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-133%
Over the last year, the Cost of Revenue growth was -75%. The average annual Cost of Revenue growth rates for Zylox-Tonbridge Medical Technology Co Ltd have been -133% over the past three years .
You don't have any saved screeners yet